Human Epilepsy Project 2: Resistant Focal Seizures Study
Diseases of the Nervous System
What is the purpose of this trial?
The Human Epilepsy Project2 (HEP2) is a prospective, observational study whose primary goal is to identify clinical characteristics and biomarkers predictive of disease outcome, progression, and treatment response in participants with treatment-resistant focal epilepsy. The data to be collected on these participants include high-resolution clinical phenotyping (including comorbidities) and treatment response, neuroimaging reports, electrophysiology reports, and biosamples for genomics, proteomics, metabolomic and transcriptome analyses. A major objective of the project is to create an open data repository of clinical information and biologic samples for future studies.
- Ages16 years - 65 years
- Trial withEpilepsy Foundation of America
- Start Date11/06/2018
- End Date07/31/2020
- Last Updated07/15/2021
- Study HIC#2000022824